Glenmede Trust’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-13,451
| Closed | -$342K | – | 1369 |
|
2023
Q2 | $342K | Hold |
13,451
| – | – | ﹤0.01% | 946 |
|
2023
Q1 | $342K | Buy |
13,451
+5,186
| +63% | +$132K | ﹤0.01% | 951 |
|
2022
Q4 | $241K | Buy |
+8,265
| New | +$241K | ﹤0.01% | 1041 |
|
2017
Q4 | – | Sell |
-117
| Closed | -$16K | – | 2805 |
|
2017
Q3 | $16K | Buy |
+117
| New | +$16K | ﹤0.01% | 2042 |
|